4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-24-079689
Chief Financial Officer sold 9,373 shares at an average $6.24 ($58,493)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2024-06-27 | Sale 10b5-1 | −295 | $6.26 | $1,847 | 339,508 | D |
| Catinazzo Thomas Chief Financial Officer | 2024-06-27 | Sale 10b5-1 | −9,078 | $6.24 | $56,647 | 330,430 | D |
| Open-market sales · 9,373 sh · avg $6.24 · $58,493 | |||||||
Loading xslF345X05/ownership.xml…